Camargo-Martínez W, Lozada-Martínez I, Escobar-Collazos A, Navarro-Coronado A, Moscote-Salazar L, Pacheco-Hernández A, et al. Post-COVID 19 neurological syndrome: Implications for sequelae’s treatment. Journal of Clinical Neuroscience. 2021 Jun 1;88:219-25.. doi:10.1016/j.jocn.2021.04.001

Panda PK, Sharawat IK, Panda P, Natarajan V, Bhakat R, Dawman L. Neurological complications of SARS-CoV-2 infection in children: a systematic review and meta-analysis. J Trop Pediatr. 2021;67:1–11

LaRovere KL, Riggs BJ, Poussaint TY, Young CC, Newhams MM, Maamari M, et al. Neurologic Involvement in children and adolescents hospitalized in the United States for COVID19 or multisystem inflammatory syndrome. JAMA Neurol. 2021;78:536–47.

Nepal G, Shrestha GS, Rehrig JH, Gajurel BP, Ojha R, Agrawal A, et al. Neurological manifestations of COVID-19 associated multi-system inflammatory syndrome in children: a systematic review and meta-analysis. J Nepal Health Res Counc. 2021;19:10–8.

Nagabushana D, Samaga VV, Shenoy S, Girishan S, V. Reddy H, AR S. Coronavirus Disease 2019-Associated Cerebral Mucormycosis in an Immunocompetent Child. Journal of Pediatric Neurology. 2022 Dec 30.

Cao-Lormeau VM, Blake A, Mons S, Lastère S, Roche C, Vanhomwegen J, et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. The Lancet. 2016 Apr 9;387(10027):1531-9..

Uncini A, González‐Bravo DC, Acosta‐Ampudia YY, Ojeda EC, Rodríguez Y, Monsalve DM, et al. Clinical and nerve conduction features in Guillain− Barré syndrome associated with Zika virus infection in Cúcuta, Colombia. European Journal of Neurology. 2018 Apr;25(4):644-50.

Chan M, Han SC, Kelly S, Tamimi M, Giglio B, Lewis A. A case series of Guillain-Barré Syndrome following Covid-19 infection in New York. Neurology: Clinical Practice. 2020 May 20.. doi:10.1212/CPJ.0000000000000880

Uncini A, Vallat J, Jacobs BC Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic. Journal of Neurology, Neurosurgery & Psychiatry 2020;91:1105-1110

McKean N, Chircop C. Guillain-Barré syndrome after COVID-19 vaccination. BMJ Case Rep. 2021; 14(7):e244125. doi:10.1136/bcr-2021-244125

Curtis M, Bhumbra S, Felker MV, Jordan BL, Kim J, Weber M, et al. Guillain-Barré syndrome in a child with COVID-19 infection. Pediatrics. 2021 Apr 1;147(4). doi:10.1542/peds.2020-015115

El Mezzeoui S, zahra Aftiss F, Aabdi M, Bkiyar H, Housni B. Guillan barre syndrome in post Covid-19 infection in children. Annals of medicine and surgery. 2021 Jul;67. doi:10.1016/j.amsu.2021.102524

Elshebawy H, Ezzeldin MY, Elzamarany EH. Characteristics of COVID and post COVID polyneuropathies in adults and pediatrics: an Egyptian sample. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2021;57(1):1-7.

Al Jaberi, M., Shihadat, R. & Masri, A. Post SARS-CoV-2 Guillain-Barré syndrome in a child: case report and review of the literature. Childs Nerv Syst 38, 2011–2016 (2022)

Virani A, Rabold E, Hanson T, Haag A, Elrufay R, Cheema T, Balaan M, Bhanot N. Guillain-Barré syndrome associated with SARS-CoV-2 infection. IDCases. 2020 Jan 1;20:e00771.. doi:10.1016/j.idcr.2020.e00771

Abdel-Mannan O, Eyre M, Löbel U, Bamford A, Eltze C, Hameed B, et al. Neurologic and radiographic findings associated with COVID-19 infection in children. JAMA neurology. 2020 Nov 1;77(11):1440-5.. doi:10.1001/jamaneurol.2020.2687

Olivotto S, Basso E, Lavatelli R, Previtali R, Parenti L, Fiori L, et al. Acute encephalitis in pediatric multisystem inflammatory syndrome associated with COVID-19. European Journal of Paediatric Neurology. 2021 Sep 1;34:84-90.. doi:10.1016/j.ejpn.2021.07.010

Chen TH. Neurological involvement associated with COVID-19 infection in children. J Neurol Sci. 2020;418:117096. doi:10.1016/j.jns.2020.117096

Abel D, Shen MY, Abid Z, Hennigan C, Boneparth A, Miller EH, et al . Encephalopathy and bilateral thalamic lesions in a child with MIS-C associated with COVID-19. Neurology. 2020 Oct 20;95(16):745-8. . doi: 10.1212/WNL.0000000000010652

Tetsuka S. Reversible lesion in the splenium of the corpus callosum. Brain Behav. (2019) 9:e01440. doi: 10.1002/brb3.1440)

Starkey J, Kobayashi N, Numaguchi Y, Moritani T. Cytotoxic lesions of the corpus callosum that show restricted diffusion: mechanisms, causes, and manifestations. Radiographics. (2017) 37:562–76. doi: 10.1148/rg.2017160085

Ahmad SA, Kakamad FH, Mohamad HS, Salih BK, Mohammed SH, Abdulla BA, et al. Post COVID-19 cerebral venous sinus thrombosis; a case report. Annals of Medicine and Surgery. 2021 Dec 1;72:103031..

Abdulgayoom M, Abdelmahmuod E, Elfaki A, Halabiya MA, Halabiya M. Cerebral venous sinus thrombosis as an unexpected complication of COVID-19 pneumonia. Cureus. 2021 Jul 19;13(7)..

Obi AT, Barnes GD, Napolitano LM, Henke PK, Wakefield TW. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection. J Vasc Surg Venous Lymphat Disord. 2021;9(1):23-35. doi:10.1016/j.jvsv.2020.08.030)

Witvoet EH, Jiang FY, Laumans W, de Bruijn SF. COVID-19-related diffuse leukoencephalopathy with microbleeds and persistent coma: a case report with good clinical outcome. BMJ Case Reports CP. 2021 Aug 1;14(8):e242504..

Lang M, Buch K, Li MD, Mehan WA, Lang AL, Leslie-Mazwi TM, et al. Leukoencephalopathy associated with severe COVID-19 infection: sequela of hypoxemia?. American Journal of Neuroradiology. 2020 Sep 1;41(9):1641-5..

Kojima H, Sakamoto N, Kosaka A, Kobayashi M, Amemiya M, Washino T, et al. COVID-19-associated leukoencephalopathy in the absence of severe hypoxia with subsequent improvement: a case report. BMC Infectious Diseases. 2022 Dec;22(1):1-5. https://doi.org/10.1186/s12879-022-07426-y)

Al Balushi A, Al Ajmi A, Al Sinani Q, Menon V, Al Berieki Z, Al Shezawi A, et al. COVID-19-associated mucormycosis: an opportunistic fungal infection. A case series and review. International Journal of Infectious Diseases. 2022 Aug 1;121:203-10.. doi:10.1016/j.ijid.2022.05.005